National and Kapodistrian University of Athens
Μελέτη του επιπολασμού της λοίμωξης από τον ιό της ηπατίτιδας C σε πληθυσμό εγκύων γυναικών και διερεύνηση της μετάδοσης του ιού από τη μητέρα στο παιδί
Abstract
dc:descriptionThe objective of this paper was assess the prevalence of anti-HCV and the rate of vertical transmission of hepatitis C virus in a random sample of pregnant women. 5.120 pregnant women attending the “Helena Venizelou” Maternity Hospital were screened for HCV antibodies by ELISA 2 and RIBA 2 methods. Anti-HCV positive women were also tested for anti-HIV antibodies and HCV RNA. Anti-HCV positive women together with an anti-HCV negative group were interviewed to collect epidemiological data. In 22 infants of 21 anti-HCV positive, anti-HIV negative mothers (1 set of twins), HCV RNA analyses by polymerase chain reaction (PCR) was performed on 3 blood samples from birth to 12 months of age (0,6,12 months). The overall anti-HCV prevalence in the pregnant women was 0,66% (34/5120). This figures is in agreement with the available data on blood donors in Greece and on healthy population in the Mediterranean area. HCV seropositivity is positively related by the transfusions and the drug abuse and negatively by the socioeconomical level. Regarding the risk factors identified in the study group, 11,8% of the anti-HCV positive women had received in the past a blood transfusion, and 11,8% at them were drug users. None of the known risk factors was identified in the 76.7% of the anti-HCV positive women. The risk of HCV vertical transmission in this study was relatively low (4,76%), probably because the sample was drawn from a low risk population. The risk of HCV vertical transmission in viremic women was higher, 7,69%. In conclusion, considering that: · HCV infection is a very serious public health issue worldwide. · The risk of HCV vertical transmission is low but non insignificant even in low-risk pregnant women. · In a considerable proportion of the anti-HCV positive women none of the known risk factors were present; We could propose that: · The prenatal anti-HCV screening to all pregnant women even those not in high-risk groups. · Infant screening born by anti-HCV positive, anti-HIV negative women could be limited in the anti-HCV detection after the first year of life. · Screening of infants born to viremic mothers should take place before their first birthday and be extend to HCV RNA detection.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2000
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Farmaki, Georgia
- Φαρμάκη, Γεωργία
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/21616